Anti-Müllerian hormone: A potential new tool in epidemiologic studies of female fecundability

American Journal of Epidemiology

Volumn 175, Issue 4, 2012, Pages 245-249

  Baird, Donna D ^a   Steiner, Anne Z ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

anti Mullerian hormone; epidemiology; fertility; research design

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ASSESSMENT METHOD; CONTRACEPTIVE USE; DATA SET; EPIDEMIOLOGY; FEMALE; HORMONE; MEASUREMENT METHOD; OCCUPATIONAL EXPOSURE; PREGNANCY; SERUM; WOMENS HEALTH;

ANOVULATION; ARTICLE; BODY MASS; CANCER THERAPY; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTRACEPTION; CROSS-SECTIONAL STUDY; FEASIBILITY STUDY; FEMALE; FEMALE FERTILITY; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; HORMONE BLOOD LEVEL; HUMAN; INFERTILITY; LIFESTYLE; MENOPAUSE; MENSTRUAL CYCLE; OCCUPATION; OVARIAN RESERVE; OVARY FOLLICLE; PATIENT SELECTION; PREGNANCY; REPRODUCTION;

ANTI-MULLERIAN HORMONE; EPIDEMIOLOGIC RESEARCH DESIGN; FEMALE; FERTILITY; HUMANS; INFERTILITY, FEMALE; PREGNANCY;

EID: 84856738596     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr439     Document Type: Article

References (53)

1. Cramer DW, Schiff I, Schoenbaum SC, et al. Tubal infertility and the intrauterine device. N Engl J Med. 1985;312(15):941-947. (Pubitemid 15111953)
2. Daling JR, Weiss NS, Metch BJ, et al. Primary tubal infertility in relation to the use of an intrauterine device. N Engl J Med. 1985;312(15):937-941. (Pubitemid 15111952)
3. Cox ML. The Dalkon Shield saga [editorial]. J Fam Plann Reprod Health Care. 2003;29(1):8.
4. Rachootin P, Olsen J. The risk of infertility and delayed conception associated with exposures in the Danish workplace. J Occup Med. 1983;25(5):394-402. (Pubitemid 13058045)
5. Olsen J, Rachootin P, Schiødt AV, et al. Tobacco use, alcohol consumption and infertility. Int J Epidemiol. 1983;12(2): 179-184. (Pubitemid 13027596)
6. Baird DD,Wilcox AJ,Weinberg CR. Use of time to pregnancy to study environmental exposures. Am J Epidemiol. 1986; 124(3):470-480. (Pubitemid 16047363)
7. Ecochard R. Heterogeneity in fecundability studies: issues and modelling. Stat Methods Med Res. 2006;15(2):141-160.
8. Scheike TH, Keiding N. Design and analysis of time-topregnancy. Stat Methods Med Res. 2006;15(2):127-140.
9. Trussell J, Wynn LL. Reducing unintended pregnancy in the United States. Contraception. 2008;77(1):1-5.
10. Joffe M. Validity of self-reported time to pregnancy. Epidemiology. 2010;21(1):160-161.
11. Baird DD, Weinberg CR, Rowland AS. Reporting errors in time-to-pregnancy data collected with a short questionnaire: impact on power and estimation of fecundability ratios. Am J Epidemiol. 1991;133(12):1282-1290.
12. Cooney MA, Buck Louis GM, Sundaram R, et al. Validity of self-reported time to pregnancy. Epidemiology. 2009;20(1): 56-59.
13. Weinberg CR, Baird DD,Wilcox AJ. Sources of bias in studies of time to pregnancy. Stat Med. 1994;13(5-7):671-681. (Pubitemid 24106747)
14. Bonde JP, Joffe M, Sallmén M, et al. Validity issues relating to time-to-pregnancy studies of fertility. Epidemiology. 2006; 17(4):347-349. (Pubitemid 44305505)
15. Slama R, Ducot B, Carstensen L, et al. Feasibility of the current-duration approach to studying human fecundity. Epidemiology. 2006;17(4):440-449. (Pubitemid 44305518)
16. Baird DD, Wilcox AJ. Cigarette smoking associated with delayed conception. JAMA. 1985;253(20):2979-2983. (Pubitemid 15032447)
17. Rogers J, Mitchell GW Jr. The relation of obesity to menstrual disturbances. N Engl J Med. 1952;247(2):53-55.
18. Wise LA, Rothman KJ, Mikkelsen EM, et al. An Internetbased prospective study of body size and time-to-pregnancy. Hum Reprod. 2010;25(1):253-264.
19. Mutsaerts MA, Groen H, ter Bogt NC, et al. The LIFESTYLE Study: costs and effects of a structured lifestyle program in overweight and obese subfertile women to reduce the need for fertility treatment and improve reproductive outcome. A randomised controlled trial. BMC Womens Health. 2010; 10(1):22. (doi:10.1186/1472-6874-10-22).
20. Brewer CJ, Balen AH. The adverse effects of obesity on conception and implantation. Reproduction. 2010;140(3): 347-364.
21. Palmer JR, Hatch EE, Rao RS, et al. Infertility among women exposed prenatally to diethylstilbestrol. Am J Epidemiol. 2001; 154(4):316-321. (Pubitemid 32756627)
22. Eskenazi B, Gold EB, Samuels SJ, et al. Prospective assessment of fecundability of female semiconductor workers. Am J Ind Med. 1995;28(6):817-831.
23. Chen PC, Hsieh GY, Wang JD, et al. Prolonged time to pregnancy in female workers exposed to ethylene glycol ethers in semiconductor manufacturing. Epidemiology. 2002;13(2): 191-196.
24. Lin CM, Chang WP, Doyle P, et al. Prolonged time to pregnancy in residents exposed to ionising radiation in cobalt-60-contaminated buildings. Occup Environ Med. 2010;67(3): 187-195.
25. Olsen J, Bonde JP, Hjøllund NH, et al. Using infertile patients in epidemiologic studies on subfecundity and embryonal loss. Hum Reprod Update. 2005;11(6):607-611. (Pubitemid 41631310)
26. Younglai EV, Holloway AC, Foster WG. Environmental and occupational factors affecting fertility and IVF success. Hum Reprod Update. 2005;11(1):43-57. (Pubitemid 40201975)
27. La Marca A, Sighinolfi G, Radi D, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16(2):113-130.
28. Lee MM, Donahoe PK, Hasegawa T, et al. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab. 1996;81(2):571-576. (Pubitemid 26055665)
29. Hagen CP, Aksglaede L, Sørensen K, et al. Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J Clin Endocrinol Metab. 2010;95(11): 5003-5010.
30. Hansen KR, Hodnett GM, Knowlton N, et al. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril. 2011;95(1): 170-175.
31. Sowers MR, Eyvazzadeh AD, McConnell D, et al. Anti-Mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab. 2008;93(9):3478-3483.
32. Broer SL, Eijkemans MJ, Scheffer GJ, et al. Anti-Mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab. 2011; 96(8):2532-2539.
33. Steiner AZ, Herring AH, Kesner JS, et al. Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years. Obstet Gynecol. 2011;117(4):798-804.
34. Decanter C, Morschhauser F, Pigny P, et al. Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results. Reprod Biomed Online. 2009;20(2):280-285.
35. Anderson RA, Cameron DA. Pretreatment serum anti-Müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. J Clin Endocrinol Metab. 2011;96(5):1336-1343.
36. Plante BJ, Cooper GS, Baird DD, et al. The impact of smoking on antimüllerian hormone levels in women aged 38 to 50 years. Menopause. 2010;17(3):571-576.
37. Sowers MR, McConnell D, Yosef M, et al. Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period. Ann N Y Acad Sci. 2010;1204(1): 95-103.
38. Seifer DB, Golub ET, Lambert-Messerlian G, et al. Variations in serum Müllerian inhibiting substance between white, black, and Hispanic women. Fertil Steril. 2009;92(5): 1674-1678.
39. Rustamov O, Pemberton PW, Roberts SA, et al. The reproducibility of serum anti-Müllerian hormone in subfertile women: within and between patient variability. Fertil Steril. 2011;95(3):1185-1187.
40. van Rooij IA, Broekmans FJ, Scheffer GJ, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril. 2005;83(4):979-987.
41. La Marca A, Stabile G, Artenisio AC, et al. Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod. 2006;21(12):3103-3107. (Pubitemid 44811610)
42. Hehenkamp WJ, Looman CW, Themmen AP, et al. Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab. 2006;91(10):4057-4063. (Pubitemid 44536885)
43. Streuli I, Fraisse T, Pillet C, et al. Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertil Steril. 2008;90(2):395-400.
44. La Marca A, Giulini S, Orvieto R, et al. Anti-Müllerian hormone concentrations in maternal serum during pregnancy. Hum Reprod. 2005;20(6):1569-1572. (Pubitemid 40852249)
45. Nelson SM, Stewart F, Fleming R, et al. Longitudinal assessment of antimüllerian hormone during pregnancy-relationship with maternal adiposity, insulin, and adiponectin. Fertil Steril. 2010; 93(4):1356-1358.
46. de Vet A, Laven JS, de Jong FH, et al. Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77(2):357-362. (Pubitemid 34083560)
47. Nelson SM, La Marca A. The journey from the old to the new AMH assay: how to avoid getting lost in the values. Reprod Biomed Online. 2011;23(4):411-420.
48. Kumar A, Kalra B, Patel A, et al. Development of a second generation anti-Müllerian hormone (AMH) ELISA. J Immunol Methods. 2010;362(1-2):51-59.
49. Venn A, Bruinsma F, Werther G, et al. Oestrogen treatment to reduce the adult height of tall girls: long-term effects on fertility. Lancet. 2004;364(9444):1513-1518. (Pubitemid 39410417)
50. Hendriks AE, Laven JS, Valkenburg O, et al. Fertility and ovarian function in high-dose estrogen-treated tall women. J Clin Endocrinol Metab. 2011;96(4):1098-1105.
51. SallménM,Weinberg CR, Baird DD, et al. Has human fertility declined over time? Why we may never know. Epidemiology. 2005;16(4):494-499. (Pubitemid 40847833)
52. Seifer DB, Baker VL, Leader B. Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil Steril. 2011; 95(2):747-750.
53. Lin YH, Chiu WC, Wu CH, et al. Antimüllerian hormone and polycystic ovary syndrome. Fertil Steril. 2011;96(1):230-235.